Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Johnson Pharmacare has informed that the Board of Directors of the Company, in their meeting held on today Monday 27th October 2025 at the Registered Office of the Company and transacted the following major business: The board has considered and accepted the resignation of Paresh Sengal from the post of Director of the Company with effect from 27.10.2025. The board meeting commenced at 04:00 pm and concluded at 04:30 pm.
The above information is a part of company’s filings submitted to BSE.
